118th Congress Health
H.R. 4626: OTC Act of 2023
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill requires the Food and Drug Administration (FDA) to issue guidance on the approval process for over-the-counter oral contraceptives so as to encourage drug manufacturers to submit applications for approval. The FDA must also evaluate (1) whether and to what extent consumers understand the labeling on oral contraceptives, and (2) whether the labeling could be improved.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Stephanie Bice R-OKOriginal
- Lori Chavez-DeRemer R-OROriginal
- Marjorie Greene R-GAOriginal
- Diana Harshbarger R-TNOriginal
- Young Kim R-CAOriginal
- Jennifer Kiggans R-VAOriginal
- Nancy Mace R-SCOriginal
- Nicole Malliotakis R-NYOriginal
- Maria Salazar R-FLOriginal
- Ashley Hinson R-IA
Who scored on this bill
No member has earned points from it yet.
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Mariannette Miller-Meeks
History
- Introduced in the House by Mariannette Miller-Meeks.
Show the full action history (3 actions)
- Referred to the Subcommittee on Health.
- Introduced in House
- Referred to the House Committee on Energy and Commerce.